Hypochlorite‐modified albumin colocalizes with RAGE in the artery wall and promotes MCP‐1 expressionviathe RAGE‐Erk1/2 MAP‐kinase pathway
Open Access
- 11 January 2007
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 21 (4) , 1145-1152
- https://doi.org/10.1096/fj.06-7439com
Abstract
Signal transduction via the endothelial receptor for advanced glycation end products (RAGE) plays a key role in vascular inflammation. Recent observations have shown that the myeloperoxidase‐H2O2‐chloride system of activated phagocytes is highly up‐regulated under inflammatory conditions where hypochlorous acid (HOCl) is formed as the major oxidant. Albumin, an in vivo carrier for myeloperoxi‐dase is highly vulnerable to oxidation and a major representative of circulating advanced oxidized proteins during inflammatory diseases. Immunohistochem‐ical studies performed in the present study revealed marked colocalization of HOCl‐modified epitopes with RAGE and albumin in sections of human atheroma, mainly at the endothelial lining. We show that albumin modified with physiologically relevant concentrations of HOCl, added as reagent or generated by the myelo‐peroxidase‐H2O2‐chloride system, is a high affinity li‐gand for RAGE. Albumin, modified by HOCl in the absence of free amino acids/carbohydrates/lipids to exclude formation of AGE‐like structures, induced a rapid, RAGE‐dependent activation of extracellular signal‐regulated kinase 1/2 and up‐regulation of the proin‐flammatory mediator monocyte chemoattractant pro‐tein‐1. Cellular activation could be blocked either by a specific polyclonal anti‐RAGE IgG and/or a specific mitogen‐activated protein‐kinase kinase inhibitor. The present study demonstrates that HOCl‐modified albumin acts as a ligand for RAGE and promotes RAGEmediated inflammatory complications.—Marsche, G., Semlitsch, M., Hammer, A., Frank, S., Weigle, B., Demling, N., Schmidt, K., Windischhofer, W., Waeg, G., Sattler, W., Malle, E. Hypochlorite‐modified albumin colocalizes with RAGE in the artery wall and promotes MCP‐1 expression via the RAGE‐Erk1/2 MAP‐kinase pathway. FASEB J. 21, 1145–1152 (2007)Keywords
Funding Information
- Austrian Science Fund (P17013-B05, P19074-B05)
- Oesterreichische Nationalbank (9962)
- Kamillo Eisner Stiftung
This publication has 41 references indexed in Scilit:
- Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cellsCell and tissue research, 2005
- Enhanced RAGE-mediated NFκB stimulation in inflamed hemodialysis patientsAtherosclerosis, 2005
- Protein GlycationCirculation Research, 2004
- AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: A potential target for N-acetylcysteine treatment in dialysis patientsKidney International, 2003
- Patterns of oxidized epitopes, but not NF-κB expression, change during atherogenesis in WHHL rabbitsAtherosclerosis, 2003
- Hypochlorite-Modified (Lipo)Proteins Are Present in Rabbit Lesions in Response to Dietary CholesterolBiochemical and Biophysical Research Communications, 2001
- Human monocyte chemoattractant protein‐1 (MCP‐1) Full‐length cDNA cloning, expression in mitogen‐stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JEPublished by Wiley ,2001
- Identification of the human analog of SR-BI and LOX-1 as receptors for hypochlorite-modified high density lipoprotein on human umbilical venous endothelial cellsThe FASEB Journal, 2001
- Advanced oxidation protein products as a novel marker of oxidative stress in uremiaKidney International, 1996
- Immunologic Detection and Measurement of Hypochlorite-Modified LDL With Specific Monoclonal AntibodiesArteriosclerosis, Thrombosis, and Vascular Biology, 1995